Details
Category: Volume 07 Issue 03 March 2019
Hits: 1511

Title: Prevalence of Hypertension, Obesity and Its Influence on Achievement of Therapeutic Goals in Indian Type 2 Diabetes Patients: A retrospective observational study at tertiary diabetes care centre in Bihar

Author: Dr Akhouri Sukrit Prakash

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.07

Abstract

Aim: The present study was conducted to observe the prevalence of hypertension, obesity and its Influence on Achievement of Therapeutic Goals in Type 2 Diabetes Patients who were attending diabetes care centre in Bihar.

Method: The observational study was undertaken at Prakash diabetes care hospital at Patna city in Bihar. A total sample of 1400 type 2 diabetes patients attending the medical outdoor patient department were studied to assess the prevalence hypertension, obesity and its influence on achievement of therapeutic goals. Anthropometric data was collected by using standard questionnaire by measuring body weight, height, west circumference and hip circumference. A mercury sphygmomanometer (Diamond Deluxe Blood Pressure apparatus, Pune, India) was used to determine the sitting blood pressure of right arm. Glycated haemoglobin (HbA1c) test was performed at hospital laboratory to determine glycemic level. 

Result: There were 42.6% subjects who were overweight and 18.2% type 2 diabetes patents were obese. Prevalence of hypertension was 79.8% in this category of subjects. Among this subjects target goals were achieved by 12.6% of subjects who were overweight and 9.6% of subjects who were obese. The subjects who were having normal BMI among both over weight and obese were less likely to achieve target glycemic goal. It was also observed that prevalence of hypertension, obesity was quite high in type 2 diabetic patients of Patna city. Subjects who had abdominal obesity with hypertension were unable to achieve target glycemic control than those without abdominal obesity and hypertension.

Conclusion: Hypertension and obesity were associated with poor glycemic control in Indian type 2 diabetes patients mainly receding at Bihar. To manage the situation a proper clinical awareness and management of obesity and hypertension is essential with lifestyle modification and strict exercise to achieve target glycemic control among type 2 diabetes subjects.

Keywords: Hypertension, Obesity, Diabetes, BMI, west circumference.

References

  1. Ranjit Mohan Anjana, Mohan Deepa, Rajendra Pradeepa, Jagadish Mahanta, Kanwar Narain, Hiranya Kumar Das, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. The Lancet Diabetes and Endocrinology, Volume 5, ISSUE 8, P585-596, August 01, 2017.
  2. McCulloch DK, Robertson RP. Risk factors for type 2 diabetes mellitus Available from: http://www.uptodate.com/contents/risk-factors-for-type-2-diabetes-mellitus.
  3. NHS Digital. National Diabetes Audit 2012-2013: report 1: care processes and treatment targets. Available from: http://www.hscic.gov.uk/catalogue/PUB14970 
  4. Lau DCW. New insights in the prevention and early management of type 2 diabetes. Can J Diabetes 2011;35:239–41.
  5. World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland: World Health Organization; 2013
  6. United Nations Population Division The World Population Prospects: 2015 Revision. New York, NY: United Nations; 2015.
  7. Geldsetzer P, Manne-Goehler J, Theilmann M, et al. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults. JAMA Intern Med. 2018;178(3):363-372.
  8. Sharma, Shilpi and Jain, Shashi. 2009. Prevalence of obesity among type 2 diabetics. J. Hum. Ecol., 25(1): 31-35.
  9. Hossain, Mohammad, Salim, Rahaman, Zahedur, Banik, Sujan, Sarwar, Shahid, Yokota, Kazushige. 2012. Prevalence of the metabolic syndrome in diabetic patients living in a coastal region of Bangladesh.. IJPSR, 3(8): 2633-263.
  10. Arner, E, Westermark, PO, Spalding, KL, Britton, T, Ryden, M, Frisen, J, et al, 2010. Adipocyte Turnover: Relevance to Human Adipose Tissue Morphology. Diabetes, 59:105-9.
  11. Eriksson J, Lindström J, Tuomilehto J. Potential for the prevention of type 2 diabetes. Oxford Journals, British Medical Bulletin. 2001;60(1):183-99.
  12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2018 Jan; 41(Supplement 1): S13-S27.
  13. IDF Diabetes Atlas I Sixth edition I 66.
  14. Centers for Disease Control and Prevention (CDC). Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988–1994 and 1999–2002. MMWR Morb Mortal Wkly Rep. 2004; 53:1066–1068.
  15. Ko GT, Chan JC, Woo J, et al. Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obes Relat Metab Disord 1997; 21: 995–1001.
  16. Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990–1994. Int J Obes Relat Metab Disord 1998; 22: 684–87.
  17. Oh SW, Shin S-A, Yun YH, Yoo T, Huh B-Y. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obesity Res 2004; 12: 2031–40.
  18. Shin CS, Lee HK, Koh CS, et al. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care 1997; 20: 1842–46.
  19. Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M. Prevalence of glucose intolerance in Asian Indians. Urban-rural diff erence and signifi cance of upper body adiposity. Diabetes Care 1992; 15: 1348–55.
  20. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 1997; 40: 232–37
  21. Jones DW, Miller ME, Wofford MR, Anderson DC Jr, Cameron ME, Willoughby DL, et al. The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study. Am J Hypertens. 1999; 12:1175–1180.
  22. Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE,et al. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2000; 2:175–187.
  23. Qin L, Knol MJ, Corpeleijn E, Stolk RP. Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol. 2010; 25:5–12. doi: 10.1007/s10654-009-9395-y.
  24. Ryan AS, Ge S, Blumenthal JB, Serra MC, Prior SJ, Goldberg AP. Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc. 2014; 62:607–614. doi: 10.1111/jgs.12749.

Corresponding Author

Dr Akhouri Sukrit Prakash

Sr. Diabetologist, Prakash Diabetes Speciality Hospital, Patna, Bihar, India